Website & contact details
- Website
Foventa Therapeutics Limited
- Incorporated
- 5 December 2013 (12 years)
- Previously known as
- Exonate Limited (until 21 August 2026)
- Industry
- Manufacture of basic pharmaceutical products (21100)
- Directors
- Olav HelleboPhil Bates
- Accounts type
- Small
- Region
- East of England
- Address
- Wtl Moorfield RoadDuxfordCambridgeCB22 4PS
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 19 December 2026
- Last conf. stmt
- 5 December 2025
Officers 7 active
Officer details are public data from the Companies House register.
Hellebo, Olav
Director · Appointed 18 June 2026
Norwegian
Born July 1965 (61)
Bates, Phil
Director · Appointed 5 March 2026
British
Born November 1966
Director · Appointed 13 May 2024
British
Born May 1968 (58)
Kurek, John
Director · Appointed 18 November 2016
Australian
Born February 1967 (59)
Director · Appointed 28 September 2015
Also at Phoremost Limited · more companies
British
Born February 1969 (57)
Director · Appointed 10 June 2014
British
Born June 1973 (53)
Director · Appointed 30 January 2014
Also at Plant Bioscience Limited · more companies
British
Born May 1957 (69)
Officer history (7 former)
18 June 2026
18 June 2026
Appointed Hellebo, Olav as Director
5 March 2026
Appointed Bates, Phil as Director
13 February 2026
13 May 2024
7 November 2022
22 July 2021
Resigned Bates, David Owen, Professor as Director
8 November 2018
27 February 2017
18 November 2016
Appointed Kurek, John as Director
4 May 2016
Resigned Hill, Adrian, Dr as Director
16 October 2015
28 September 2015
17 July 2014
Appointed Hill, Adrian, Dr as Director
10 June 2014
10 June 2014
10 June 2014
15 April 2014
Resigned Venning, Bruce Martyn, Dr as Secretary
30 January 2014
5 December 2013
Appointed Venning, Bruce Martyn, Dr as Secretary
5 December 2013
Appointed Bates, David Owen, Professor as Director
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- (£5,609,374)
- Cash
- £1,108,416
- Profit Before Tax
- (£1,714,870)
- Debt Ratio
- 559%
- Current Ratio
- 2.5x
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £1,366 | £9,464 | £29,279 | £92,182 | £124,637 | £19,943 |
| Current Assets | £1,221,319 | £2,529,105 | £5,477,418 | £5,125,470 | £7,548,185 | £6,266,036 |
| Debtors | £112,903 | £519,652 | £1,555,033 | £1,524,369 | £3,760,240 | £5,504,840 |
| Cash | £1,108,416 | £2,009,453 | £3,922,385 | £3,601,101 | £3,787,945 | £761,196 |
| Creditors (< 1 year) | £483,984 | £338,982 | £1,141,667 | £1,024,148 | £763,686 | £1,399,220 |
| Creditors (> 1 year) | £6,348,075 | £6,183,428 | £5,795,816 | £5,599,679 | £5,477,596 | £5,066,785 |
| Net Current Assets | £737,335 | £2,190,123 | £4,335,751 | £4,101,322 | £6,784,499 | £4,866,816 |
| Net Assets | (£5,609,374) | (£3,983,841) | (£1,430,786) | (£1,406,175) | £1,431,540 | (£180,026) |
| Shareholder Funds | (£5,609,374) | (£3,983,841) | (£1,430,786) | (£1,406,175) | £1,431,540 | (£180,026) |
Filings 87
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 27 October 2026 | Accounts for a small company | 31 December 2025 | ||
| 13 October 2026 | Statement of capital following an allotment of shares | |||
| 9 October 2026 | Other filing | |||
| 1 October 2026 | Accounts for a small company | 31 December 2025 | ||
| 1 September 2026 | Resolutions |
Other companies in this industry
Cheshire
Liverpool
Crewe
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →